Modular Medical, Inc. announced a collaboration agreement with Glooko, Inc. Integrating with Glooko will allow clinicians and patients to easily review insulin dosing data from the MODD1 pump, when commercially available. In addition, through Glooko's platform, Dexcom CGMS users will be able to view their glucose levels in the same accessible format in conjunction with their pump data. Glooko's platform has a broad installed base, which has been deployed in over 30 countries and 8,000 clinical locations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +5.33% | -3.07% | -13.19% |
Feb. 13 | Modular Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Modular Medical Announces Collaboration with Glooko | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.19% | 48.96M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- MODD Stock
- News Modular Medical, Inc.
- Modular Medical Announces Collaboration with Glooko